Related Experiment Video
Updated: Mar 3, 2026

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2
Marian Blanca Ramírez1, Antonio Jesús Lara Ordóñez1, Elena Fdez1
1Institute of Parasitology and Biomedicine 'López-Neyra', Consejo Superior de Investigaciones Científicas (CSIC), 18016 Granada, Spain.
Abstract:
Mutations in leucine-rich repeat kinase 2 (LRRK2) comprise the most common cause of familial Parkinson's disease (PD), and sequence variants modify risk for sporadic PD. Previous studies indicate that LRRK2 interacts with microtubules (MTs) and alters MT-mediated vesicular transport processes. However, the molecular determinants within LRRK2 required for such interactions have remained unknown. Here, we report that most pathogenic LRRK2 mutants cause relocalization of LRRK2 to filamentous structures which colocalize with a subset of MTs, and an identical relocalization is seen upon pharmacological LRRK2 kinase inhibition. The pronounced colocalization with MTs does not correlate with alterations in LRRK2 kinase activity, but rather with increased GTP binding. Synthetic mutations which impair GTP binding, as well as LRRK2 GTP-binding inhibitors profoundly interfere with the abnormal localization of both pathogenic mutant as well as kinase-inhibited LRRK2. Conversely, addition of a non-hydrolyzable GTP analog to permeabilized cells enhances the association of pathogenic or kinase-inhibited LRRK2 with MTs. Our data elucidate the mechanism underlying the increased MT association of select pathogenic LRRK2 mutants or of pharmacologically kinase-inhibited LRRK2, with implications for downstream MT-mediated transport events.
Insights
Mutations in leucine-rich repeat kinase 2 (LRRK2) link to Parkinson's disease. Pathogenic LRRK2 mutants and kinase inhibitors abnormally associate with microtubules (MTs) via increased GTP binding, impacting MT transport.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Mutations in leucine-rich repeat kinase 2 (LRRK2) are the leading genetic cause of Parkinson's disease (PD).
- LRRK2 is known to interact with microtubules (MTs), influencing MT-mediated transport, but the specific molecular mechanisms remain unclear.
Purpose of the Study:
- To identify the molecular determinants within LRRK2 responsible for its interaction with microtubules.
- To elucidate the mechanism by which pathogenic LRRK2 mutants and kinase inhibitors associate with MTs.
Main Methods:
- Investigated the localization of LRRK2 mutants and kinase-inhibited LRRK2 in relation to MTs.
- Assessed the role of LRRK2 GTP binding and kinase activity in MT association using synthetic mutations and pharmacological inhibitors.
- Utilized permeabilized cell assays with GTP analogs to study LRRK2-MT interactions.
Main Results:
- Pathogenic LRRK2 mutants and pharmacologically inhibited LRRK2 relocalize to filamentous structures colocalizing with MTs.
- This MT association is driven by increased GTP binding, not altered kinase activity.
- Impairing GTP binding or inhibiting LRRK2 GTP binding prevents abnormal MT localization.
- Non-hydrolyzable GTP analogs enhance LRRK2 association with MTs.
Conclusions:
- GTP binding, rather than kinase activity, dictates the abnormal association of pathogenic LRRK2 mutants and kinase-inhibited LRRK2 with microtubules.
- This finding provides a mechanistic understanding of LRRK2's MT interactions and their potential impact on MT-mediated transport in Parkinson's disease.
Related Concept Videos
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation
Activation and Inactivation of G Proteins
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Amplifying Signals via Enzymatic Cascade
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...

